Moberg Pharma completes divestment of Fiber Choice for $6.7 million
STOCKHOLM, August 28th 2017, Moberg Pharma AB (OMX: MOB) has completed the divestment of the Fiber Choice® brand to Caret Pharma LLC. for a total consideration of $6.7 million plus the inventory value. The divestment results in a capital gain of circa $1.6 million.Divesting Fiber Choice® enables Moberg Pharma to further focus resources on its core businesses. The divested brand originated from an acquisition in 2016 where the primary purpose was to acquire New Skin® and Dermoplast®, two strategic assets in specialty skin care. This divestment of Fiber Choice® results in a capital gain of